Saturday 17 October 2026
Export ELMD’s income statement to Excel — free account
Electromed, Inc.
ELMD Healthcare Medical Devices
Electromed, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $73.8 million, up 15.3% from fiscal 2025. In the quarter to June 2026, revenue grew 11.6%, EPS grew 57.7% and free cash flow fell 25.2%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
27.42
0.61
−2.18%
Follow ELMD
| Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 | Jun '20 | Jun '19 | Jun '18 | Jun '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
8 | 8 | 8 | 7 | 4 | 4 | 7 | 5 | 4 | 5 |
P/E ratio |
30.88 | 24.99 | 23.58 | 28.18 | 34.43 | 40.32 | 31.41 | 22.04 | 23.48 | 20.48 |
P/S ratio |
4.74 | 2.90 | 2.21 | 1.89 | 1.96 | 2.70 | 3.98 | 1.40 | 1.57 | 1.75 |
Altman Z-Score |
20.30 | 13.64 | 12.98 | 9.37 | 9.39 | 15.05 | 28.87 | 10.10 | 8.11 | 9.53 |
Altman Z″-Score (non-manufacturers) |
11.89 | 10.99 | 12.99 | 11.04 | 11.06 | 13.92 | 17.92 | 13.74 | 10.93 | 11.19 |
P/FCF ratio |
41.80 | 16.77 | 13.97 | 0.00 | 0.00 | 36.79 | 40.17 | 36.52 | 23.69 | 89.64 |
Beneish M-Score |
(2.20) | (2.76) | (2.79) | (2.17) | (1.99) | (2.38) | (2.33) | (2.34) | (2.56) | (2.07) |
P/Operating CF |
116.78 | 48.17 | 26.99 | 90.74 | (110.50) | 128.44 | 100.74 | 30.99 | 77.70 | 117.26 |
P/B ratio |
6.48 | 4.30 | 2.72 | 2.41 | 2.39 | 2.98 | 4.28 | 1.71 | 1.96 | 2.37 |
Price to Tangible BV |
6.52 | 4.34 | 2.76 | 2.45 | 2.43 | 3.05 | 4.36 | 1.75 | 2.02 | 2.46 |
EV/Sales |
4.48 | 2.68 | 1.94 | 1.76 | 1.79 | 2.40 | 3.70 | 1.19 | 1.38 | 1.58 |
EV/EBITDA |
22.09 | 15.55 | 14.31 | 18.27 | 20.73 | 22.92 | 20.48 | 9.91 | 11.13 | 9.39 |
EV/Operating CF |
34.18 | 15.08 | 11.71 | 64.19 | (108.81) | 27.93 | 28.60 | 14.38 | 15.99 | 34.21 |
EV/FCF |
39.49 | 15.49 | 12.25 | (210.50) | (33.76) | 32.69 | 37.28 | 30.95 | 20.88 | 80.86 |
Quick Ratio |
4.21 | 3.86 | 5.13 | 3.91 | 4.08 | 6.23 | 7.93 | 5.63 | 4.01 | 5.36 |
Current Ratio |
4.69 | 4.31 | 5.75 | 4.69 | 4.83 | 6.83 | 9.38 | 6.72 | 4.85 | 6.38 |
Net Debt/EBITDA |
(1.37) | (1.38) | (2.17) | (1.60) | (2.26) | (3.17) | (1.78) | (2.07) | (1.81) | (1.02) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.22% | 0.10% | 4.02% | 4.98% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.06 |
Asset Turnover |
1.23 | 1.21 | 1.12 | 1.10 | 1.06 | 1.02 | 1.04 | 1.10 | 1.12 | 1.19 |
Operating CF/Net income |
0.86 | 1.51 | 1.76 | 0.42 | (0.30) | 1.30 | 1.01 | 1.31 | 1.33 | 0.53 |
Capex/Depreciation |
(1.21) | (0.22) | (0.47) | (2.80) | (2.43) | (0.73) | (1.32) | (1.50) | (0.72) | (0.89) |
Interest Coverage |
— | — | — | (51.38) | (118.88) | (116.30) | (42.30) | (31.20) | (136.30) | 71.53 |
| 23.26% | 17.18% | 12.53% | 8.81% | 6.92% | 7.54% | 14.86% | 8.20% | 8.79% | 12.59% | |
| 18.82% | 14.22% | 10.51% | 7.26% | 5.87% | 6.71% | 13.28% | 6.97% | 7.26% | 10.22% | |
ROIC |
25.87% | 21.62% | 14.45% | 8.27% | 7.14% | 9.56% | 16.12% | 9.85% | 10.44% | 15.24% |
Return on Tangible Assets |
22.44% | 19.16% | 12.36% | 8.94% | 7.21% | 7.70% | 14.44% | 8.09% | 8.49% | 11.81% |
Average Days of Receivables |
153.24 | 142.97 | 155.65 | 183.23 | 184.45 | 173.86 | 148.41 | 148.80 | 152.30 | 140.43 |
Research and Development Expense of Revenue |
1.78% | 1.56% | 1.20% | 1.91% | 3.25% | 4.82% | 3.23% | 1.86% | 0.89% | 2.31% |
Selling, General and Administrative Expense of Revenue |
57.94% | 61.43% | 63.03% | 65.73% | 65.09% | 62.77% | 61.42% | 65.29% | 66.45% | 63.42% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
Share Based Compensation of Revenue |
3.69% | 4.78% | 3.09% | 1.47% | 2.34% | 2.86% | 2.78% | 2.95% | 3.05% | 1.85% |
Graham Net Nets |
0.13 | 0.19 | 0.30 | 0.33 | 0.33 | 0.28 | 0.19 | 0.48 | 0.42 | 0.32 |
Graham Number |
14.19 | 10.06 | 8.38 | 6.17 | 5.04 | 4.88 | 6.30 | 4.09 | 3.77 | 3.77 |
Earnings Yield |
3.24% | 4.00% | 4.24% | 3.55% | 2.90% | 2.48% | 3.18% | 4.54% | 4.26% | 4.88% |
Free Cash Flow Yield |
2.39% | 5.96% | 7.16% | (0.44%) | (2.71%) | 2.72% | 2.49% | 2.74% | 4.22% | 1.12% |
Revenue per Share |
8.93 | 7.57 | 6.39 | 5.68 | 4.92 | 4.17 | 3.86 | 3.77 | 3.45 | 3.17 |
Operating CF per Share |
1.17 | 1.35 | 1.06 | 0.16 | (0.08) | 0.36 | 0.50 | 0.31 | 0.30 | 0.15 |
Capex per Share |
(0.16) | (0.04) | (0.05) | (0.20) | (0.18) | (0.05) | (0.12) | (0.17) | (0.07) | (0.08) |
Free Cash Flow per Share |
1.01 | 1.31 | 1.01 | (0.05) | (0.26) | 0.31 | 0.38 | 0.14 | 0.23 | 0.06 |
Cash per Share |
2.47 | 1.81 | 1.88 | 0.87 | 0.96 | 1.39 | 1.25 | 0.94 | 0.91 | 0.68 |
Shareholders Equity per Share |
6.53 | 5.11 | 5.20 | 4.45 | 4.03 | 3.78 | 3.60 | 3.10 | 2.75 | 2.33 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6.53 | 5.11 | 5.20 | 4.45 | 4.03 | 3.78 | 3.60 | 3.10 | 2.75 | 2.33 |
Free Cash Flow |
8.37 | 11.09 | 8.67 | (0.40) | (2.21) | 2.63 | 3.22 | 1.20 | 1.87 | 0.50 |
Working Capital |
45.15 | 34.61 | 36.50 | 29.73 | 27.39 | 27.07 | 25.04 | 20.89 | 18.48 | 15.58 |
Capital Expenditures |
(1.30) | (0.31) | (0.39) | (1.72) | (1.52) | (0.45) | (0.98) | (1.39) | (0.57) | (0.69) |
Net Current Asset Value |
45.08 | 34.49 | 36.48 | 29.65 | 27.35 | 27.01 | 25.03 | 20.87 | 18.48 | 14.48 |
EV/EBIT |
23.80 | 17.78 | 16.14 | 21.06 | 25.12 | 27.37 | 23.45 | 13.16 | 14.40 | 11.41 |
Capex to Sales |
0.02 | 0.00 | 0.01 | 0.04 | 0.04 | 0.01 | 0.03 | 0.04 | 0.02 | 0.03 |
Price to Operating Income |
25.19 | 19.24 | 18.41 | 22.62 | 27.48 | 30.80 | 25.27 | 15.53 | 16.34 | 12.65 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.21 | 0.29 | 0.16 | 0.11 | 0.14 | 0.17 | 0.20 | 0.26 | 0.26 | 0.23 |
Cash ROIC |
11.24% | 18.95% | 14.30% | (0.89%) | (5.22%) | 5.93% | 7.89% | 3.58% | 6.01% | 1.95% |
Accounts Receivable Turnover |
2.63 | 2.64 | 2.31 | 2.13 | 2.19 | 2.37 | 2.50 | 2.55 | 2.60 | 2.91 |
Accounts Payable Turnover |
5.96 | 7.63 | 10.91 | 8.77 | 10.50 | 13.62 | 12.73 | 10.67 | 8.87 | 8.45 |
Inventory Turnover |
4.54 | 4.00 | 3.27 | 3.12 | 3.86 | 3.25 | 2.55 | 2.92 | 2.59 | 2.10 |
Average Days of Payables |
60.93 | 69.39 | 28.38 | 43.37 | 45.05 | 29.59 | 27.91 | 28.73 | 45.28 | 45.75 |
Days of Inventory on Hand |
84.86 | 85.83 | 104.30 | 133.41 | 113.53 | 91.30 | 154.87 | 128.43 | 138.91 | 176.51 |
Average Receivables |
28.02 | 24.20 | 23.73 | 22.59 | 19.04 | 15.12 | 12.98 | 12.29 | 10.88 | 8.88 |
Average Payables |
2.66 | 1.84 | 1.19 | 1.32 | 0.97 | 0.62 | 0.57 | 0.70 | 0.74 | 0.63 |
Average Inventory |
3.49 | 3.51 | 3.97 | 3.70 | 2.65 | 2.60 | 2.85 | 2.55 | 2.52 | 2.52 |
Average Assets |
60.03 | 53.02 | 49.02 | 43.59 | 39.24 | 35.18 | 31.32 | 28.40 | 25.23 | 21.82 |
Average Common Equity |
48.59 | 43.88 | 41.11 | 35.92 | 33.29 | 31.33 | 27.99 | 24.16 | 20.83 | 17.71 |
Columns are period end dates